The Role of UPC2 Gene in Azole-Resistant Candida tropicalis

Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates

(2016) Min Ji Choi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Molecular mechanisms associated with Fluconazole resistance in clinicalCandida albicansisolates from India

(2015) Arati Mane et al.   MYCOSES

Antifungal Activity of Naphthoquinoidal Compounds In Vitro against Fluconazole-Resistant Strains of Different Candida Species: A Special Emphasis on Mechanisms of Action on Candida tropicalis

(2014) João B. A. Neto et al.   PLoS One

Candida albicanspathogenicity mechanisms

(2013) François L. Mayer et al.   Virulence

Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China

(2012) C. Jiang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The stepwise acquisition of fluconazole resistance mutations causes a gradual loss of fitness inCandida albicans

(2012) Christoph Sasse et al.   MOLECULAR MICROBIOLOGY

Transcriptional Profiling of Azole-Resistant Candida parapsilosis Strains

(2011) A. P. Silva et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In Vivo Systematic Analysis of Candida albicans Zn2-Cys6 Transcription Factors Mutants for Mice Organ Colonization

(2011) Patrick Vandeputte et al.   PLoS One

An A643V Amino Acid Substitution in Upc2p Contributes to Azole Resistance in Well-Characterized Clinical Isolates ofCandida albicans

(2010) Samantha J. Hoot et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Hypersusceptibility to Azole Antifungals in a Clinical Isolate of Candida glabrata with Reduced Aerobic Growth

(2009) P. Vandeputte et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A Gain-of-Function Mutation in the Transcription Factor Upc2p Causes Upregulation of Ergosterol Biosynthesis Genes and Increased Fluconazole Resistance in a ClinicalCandida albicansIsolate

(2008) Nico Dunkel et al.   EUKARYOTIC CELL